Delivery Order SPE2DX22D0049-SPE2D826FA6ZB
Award Date 4/22/26
Potential Completion Date 4/23/26
Potential Value $1.8M
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency's Medical Supply Chain issued a $285,762.81 delivery order to AmerisourceBergen Drug Corp on April 16, 2026, for pharmaceutical distribution under the DLA Troop Support Medical indefinite delivery contract. Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of April 17, 2026. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor supplying brand-name and generic...
- The Defense Logistics Agency's Medical Supply Chain issued a $60,752.64 delivery order to AmerisourceBergen Drug Corp on April 20, 2026, under the DLA Troop Support Medical indefinite delivery contract for pharmaceutical distribution. Place of performance is Conshohocken, PA. The order carries a firm fixed-price structure with an ultimate completion date of April 21, 2026. AmerisourceBergen, a subsidiary of Cencora, Inc., is a pharmaceutical distributor supplying brand-name and generic...
- The Defense Logistics Agency's Medical Supply Chain issued a $398,970 delivery order to AmerisourceBergen Drug Corp on April 20, 2026, for pharmaceutical distribution under the DLA Troop Support Medical indefinite delivery contract. Place of performance is Conshohocken, PA. The order carries a firm fixed price structure with an ultimate completion date of April 21, 2026. AmerisourceBergen operates as the execution entity for DLA pharmaceutical distribution under its parent company Cencora, Inc.
- The Defense Logistics Agency's Medical Supply Chain issued a $205,054.17 delivery order to AmerisourceBergen Drug Corp on April 20, 2026, for pharmaceutical distribution to military healthcare facilities. The order is issued under a DLA Troop Support Medical indefinite delivery contract and carries a firm fixed-price structure. Place of performance is Conshohocken, PA. The order's ultimate completion date is April 21, 2026. AmerisourceBergen, a subsidiary of Cencora, Inc., operates as a...
- The Defense Logistics Agency's Medical Supply Chain issued a $1,945,695.63 delivery order to Amerisourcebergen Drug Corp on April 22, 2026, for pharmaceutical supply under a DLA Troop Support Medical indefinite delivery contract. Place of performance is Conshohocken, PA. The order carries a firm fixed-price structure with ultimate completion by April 23, 2026. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., operates as a pharmaceutical distributor supplying brand-name and generic...
- The Defense Logistics Agency's Medical Supply Chain issued a $65,140.14 delivery order to AmerisourceBergen Drug Corp on April 20, 2026, for pharmaceutical supply under a DLA Troop Support Medical indefinite delivery contract. Ultimate completion is April 21, 2026. Place of performance is Conshohocken, PA. The order is firm fixed-price with no set-aside. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., and operates as the execution entity for DLA pharmaceutical distribution,...
- The Defense Logistics Agency Medical Supply Chain issued a $534,338.14 delivery order to AmerisourceBergen Drug Corp on April 1, 2026, for pharmaceutical distribution under the DLA Troop Support Medical Indefinite Delivery Contract. Place of performance is Conshohocken, PA. The order carries a firm fixed price and is due for ultimate completion on April 2, 2026. AmerisourceBergen Drug Corp operates as a division of parent company Cencora, Inc. and holds a $999,999,999.00 indefinite delivery...
- The Defense Logistics Agency's Medical Supply Chain issued a $72,540 delivery order to AmerisourceBergen Drug Corp on April 20, 2026, under the DLA Troop Support Medical indefinite delivery contract for pharmaceutical distribution to military healthcare facilities. Place of performance is Conshohocken, PA. The order carries a firm fixed-price structure and an ultimate completion date of April 21, 2026. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., operates as the execution entity...
- The Defense Logistics Agency's Medical Supply Chain issued a $16,684.20 delivery order to AmerisourceBergen Drug Corp on April 20, 2026, under the DLA Troop Support Medical indefinite delivery contract for pharmaceutical supply to military healthcare facilities. Place of performance is Conshohocken, PA. The order carries a firm fixed-price structure with an ultimate completion date of April 21, 2026. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., operating as a pharmaceutical...
- The Defense Logistics Agency's Medical Supply Chain issued a $181,361.88 delivery order to Amerisourcebergen Drug Corp on April 23, 2026, for pharmaceutical distribution under a DLA Troop Support Medical indefinite delivery contract, with ultimate completion on April 24, 2026. Place of performance is Conshohocken, PA. The order is priced firm fixed price with no set-aside applied. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and operates as the primary pharmaceutical...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D826FA6ZBDelivery Order
The Defense Logistics Agency's Medical Supply Chain issued a $1.794 million delivery order to AmerisourceBergen Drug Corp on April 22, 2026, for pharmaceutical distribution under the DLA Troop Support Medical indefinite delivery contract. Place of performance is Conshohocken, PA. The order carries a firm fixed-price structure with an ultimate completion date of April 23, 2026. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., and operates as the execution entity for DLA pharmaceutical distribution, supplying brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical devices to Defense Health Agency and military medical facilities globally.
Generated 7/21/26, 10:23 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8m | 4/21/26 |